PRDM9 and colorectal cancer: Another set of findings, focused on colorectal cancer cells, highlighted the significant downregulation of EZH2 histone methyltransferase by statins, particularly when used in combination with HDAC5 inhibitor, leading to an augmented expression of p27.254